Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Unicycive Therapeutics, Inc. (UNCY) had Weighted-Average Shares Outstanding (Diluted) of 12.38M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.21M |
|
-- |
|
-- |
|
$7.99M |
|
$-7.99M |
|
$8.56M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$-7.99M |
|
$-7.85M |
|
11.68M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
12.38M |
$0.00 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$27.35M |
|
$0.08M |
|
$0.60M |
|
$27.95M |
|
$16.68M |
|
-- |
|
-- |
|
$16.68M |
|
$11.27M |
|
$11.27M |
|
$11.27M |
|
11.97M |
|
| Cash Flow Statement Financials | |
$-8.90M |
|
$-0.02M |
|
$2.55M |
|
$26.14M |
|
$19.77M |
|
$-6.37M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
5.06% |
|
5.06% |
|
2.04% |
|
5.06% |
|
$0.94 |
|
$-0.72 |
|
$-0.72 |
|